Moving Toward the Autonomous Lab of the Future—and What’s Possible Today

As Emerson life sciences expert Michalle Adkins recently wrote in Pharmaceutical Processing World, while a fully autonomous lab may still be several years away, industry leaders today are beginning to seriously consider what’s possible technologically, and how to invest. By collaborating on a list of achievable objectives, life sciences stakeholders worldwide can work to benefit from the earliest stages of innovation together.

Such an approach will help deliver that ideal future state more quickly, and in doing so, continually improve the progress of life sciences product pipelines in the present. This is why Emerson is leading the race to engineer AI-powered automation architectures that enable fastest-to-value manufacturing processes, but that are also tested, trusted and secure enough for regulated industries like the pharma space.